Thermo Fisher (TMO) Tops Q4 EPS by 3c; Issues In-Line FY12 EPS Outlook, Revs Light
Tweet
Share
E-mailGet Alerts TMO Hot Sheet
Price: $469.35 +1.15%
Revenue Growth %: +7.9%
Financial Fact:
Other Expense, Net: -113.2M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +7.9%
Financial Fact:
Other Expense, Net: -113.2M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $1.18, $0.03 better than the analyst estimate of $1.15. Revenue for the quarter came in at $3.13 billion versus the consensus estimate of $3.08 billion.
Thermo Fisher Scientific sees FY2012 EPS of $4.67-$4.82, versus the consensus of $4.72. Sees FY2012 revenue of $12.15-$12.35 billion, versus the consensus of $12.56 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Thermo Fisher Scientific sees FY2012 EPS of $4.67-$4.82, versus the consensus of $4.72. Sees FY2012 revenue of $12.15-$12.35 billion, versus the consensus of $12.56 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- After-Hours Stock Movers: FDX, CBRS, NKE
- BofA lists top 5 themes driving next $1tn in incremental semi sales
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
